Samantha A Hershenfeld
Overview
Explore the profile of Samantha A Hershenfeld including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
11
Followers
0
Related Specialty
Related Specialty
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Shelton V, Detroja R, Liu T, Isaev K, Silva A, Passerini V, et al.
Blood Cancer J
. 2024 Aug;
14(1):128.
PMID: 39112453
Follicular lymphoma (FL) exhibits considerable variability in biological features and clinical trajectories across patients. To dissect the diversity of FL, we utilized a Bernoulli mixture model to identify genetic subtypes...
2.
Hershenfeld S, Tobin J, Shelton V, Calvente L, Lajkosz K, Liu T, et al.
Br J Haematol
. 2024 Aug;
205(5):1810-1814.
PMID: 39112220
Radiotherapy is routinely used for management of limited-stage follicular lymphoma (FL), yet half of patients ultimately relapse. We hypothesized that the presence of specific gene mutations may predict outcomes. We...
3.
Hershenfeld S, Atenafu E, Chan S, Gupta V, Maze D, Schuh A, et al.
Acta Haematol
. 2023 Jun;
146(5):366-372.
PMID: 37315549
Introduction: Care for patients with acute myeloid leukemia (AML) is centralized in the Ontario single-payer public healthcare system, with intensive induction chemotherapy and clinical trials only offered at specialized cancer...
4.
Hershenfeld S, Maki K, Rothfels L, Murray C, Nixon S, Schimmer A, et al.
Leuk Res
. 2017 Jun;
59:93-96.
PMID: 28599190
Acute myeloid leukemia (AML) is frequently treated with induction and consolidation chemotherapy. Consolidation chemotherapy can be delivered on an ambulatory basis, requiring some patients to travel long distances for treatment...